To verify the results of data analysis, we selected a common immune cell marker CD3 for immunohistochemical tests on tissues from three pancreatic cancer patients with high TFRC expression and observed numerous inflammatory infiltrates (Figure 9B). This evidence concerns the gene TFRC and pancreatic neoplasm.